Vonovia SE
XETRA:VNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vonovia SE
XETRA:VNA
|
DE |
|
H
|
Homology Medicines Inc
XBER:35H
|
US |
Wall St Price Targets
VNA Price Targets Summary
Vonovia SE
According to Wall Street analysts, the average 1-year price target for VNA is 31.31 EUR with a low forecast of 20.2 EUR and a high forecast of 55.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VNA's stock price target?
Price Target
31.31
EUR
According to Wall Street analysts, the average 1-year price target for VNA is 31.31 EUR with a low forecast of 20.2 EUR and a high forecast of 55.55 EUR.
What is the Revenue forecast for Vonovia SE?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is -1%.
What is the Gross Profit forecast for Vonovia SE?
Projected CAGR
-8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 1 year is -8%.
What is the Operating Income forecast for Vonovia SE?
Projected CAGR
95%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 1 year is 95%.
What is the Pre-Tax Income forecast for Vonovia SE?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 21%. The projected CAGR for the next 3 years is -1%.
What is the Net Income forecast for Vonovia SE?
Projected CAGR
-21%
Over the last 13 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is -21%.
